Genmab — Januar 2026

[peter12]

Fandt nogle positive artikler på yahoo finance https://www.investors.com/stock-lists/stock-spotlight/genmab-biotech-stock-gmab-fights-cancer-buy-zone-earnings-soar

[JKY_VH]

Det må vel hænge sammen med Novods jobskifte (fra Nordea til Novo)
"We suspend coverage of Genmab owing to changes in analyst coverage. Our most
recent recommendation on Genmab was Buy, with a target price of DKK 2,021"

[E_L]

Genmab to Present at the 44th Annual J.P. Morgan Healthcare Conference 3:45 PM PST / 6:45 PM EST on January 13, 2026, 12:45 AM CET on January 14, 2026. https://ir.genmab.com/news-releases/news-release-details/genmab-present-44th-annual-jp-morgan-healthcare-conference

[Bella1]

Godt Nytår, - kørte vi lige over et søm?

[E_L]

biotech indices all down ~2% from the US open... Novo an exception in a red healthcare market

[Bella1]

Tak, E L

[Raun]

Stadig ser jeg fløjtende ligegyldigt om der kommer gode/dårlige nyheder - om indeks eller renter går op og ned.... - Genmab er i en skruetvinge og spørgsmålet er hvornår den bliver sluppet.

[gdn55]

Enig Raun

[LP90]

Godmorgen

[JKY_VH]

Fra MW "Genmab (+0,1%, 2010,00) har fået løftet sit kursmål til 2500 kr. fra 2350 kr. af svenske SEB Bank. Analytiker Thomas Bowers gentager samtidig anbefalingen "køb", fremgår det af data fra Bloomberg News. "

[ProinvestorNEWS]

Europæiske life science-aktier tager teten efter afvist sparemanøvre fra Trump https://proinvestor.com/investornyt/1400080/europaeiske-life-science-aktier-tager-teten-efter-afvist-sparemanovre-fra-trump

[E_L]

Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI▼ (teclistamab) in combination with DARZALEX (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-application-to-the-european-medicines-agency-for-tecvayli-teclistamab-in-combination-with-darzalex-daratumumab-subcutaneous-formulation-for-patients-with-relapsed-refractory-multiple-myeloma

[E_L]

genmab was still adding hospitals to the ABBIL1TY NSCLC trial just last month... probably testament to how sudden the decision was to stop acasunlimab development
... https://clinicaltrials.gov/study/NCT06635824?tab=history&a=14&b=15#version-content-panel

[E_L]

Charlie Haywood
Bank of America Securities
Buy Kr.2,250.00 Maintained Today 6-1-26

[E_L]

Deutsche Bank analyst Emmanuel Papadakis raised the price target on Genmab to 2400 (2000) and reiterated a Buy rating ( i t thought he did that last month already...?)

[JKY_VH]

Man skulle næsten tro, at jeg har solgt mine Genmab aktier:-)

[concillado]

Genmab har også noget at indhente, hvis kurstendensen fra sidste år skal gentages i år

[Raun]

Tør man håbe på at dette er et tegn på at aktien endelig skal have lov at udvikle sig naturligt?

[concillado]

20 min til luk og kursen er nu steget over 5%

[concillado]

Lad os se i morgen, hvor mange som skummer